1. Home
  2. CRMD vs MFIC Comparison

CRMD vs MFIC Comparison

Compare CRMD & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorMedix Inc.

CRMD

CorMedix Inc.

N/A

Current Price

$7.36

Market Cap

695.9M

Sector

Health Care

ML Signal

N/A

Logo MidCap Financial Investment Corporation

MFIC

MidCap Financial Investment Corporation

N/A

Current Price

$9.85

Market Cap

818.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CRMD
MFIC
Founded
2006
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
695.9M
818.0M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CRMD
MFIC
Price
$7.36
$9.85
Analyst Decision
Strong Buy
Hold
Analyst Count
6
7
Target Price
$14.83
$11.25
AVG Volume (30 Days)
920.3K
420.8K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
10.84%
EPS Growth
780.00
N/A
EPS
0.43
N/A
Revenue
$311,709,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.72
$10.50
Revenue Growth
617.03
N/A
52 Week Low
$6.13
$9.34
52 Week High
$14.96
$13.34

Technical Indicators

Market Signals
Indicator
CRMD
MFIC
Relative Strength Index (RSI) 35.80 49.46
Support Level $7.05 $9.57
Resistance Level $7.44 $10.15
Average True Range (ATR) 0.37 0.22
MACD -0.11 0.02
Stochastic Oscillator 5.42 72.86

Price Performance

Historical Comparison
CRMD
MFIC

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. The investment objective of the company is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

Share on Social Networks: